CIK 0000072444
- Accelerated filer
- Smaller reporting company
Vaxart, Inc.
Sign in to watch- Ticker
- VXRT
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 591212264
- Phone
- +1 650-550-3500
- Business address
- 310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, CA
- Former names
- Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., NABI BIOPHARMACEUTICALS, NABI BIOPHARMACEUTICALS, NABI /DE/, NORTH AMERICAN BIOLOGICALS INC
- 4 Grant or award Director acquired 7,375 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 22,500 shares (grant or award)
- 4/A Grant or award Chief Financial Officer acquired 101,652 shares (grant or award)
- 4 Grant or award President, Chief Exec Officer acquired 367,735 shares (grant or award)
- 4 Grant or award SVP, General Counsel acquired 187,606 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 191,652 shares (grant or award)
- 4 Grant or award SVP, Chief Scientific Officer acquired 189,157 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 194,350 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 68,750 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 20,000 shares at $0.76 ($15,140)
- 4 Open-market sale Director sold 1,500 shares at $6.01 ($9,015)
- 4 Gift Director gave 26,240 shares (gift)
- 4 Grant or award Director acquired 14,750 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Option exercise Director acquired 26,240 shares (option exercise)
- 4 Grant or award Director acquired 14,750 shares (grant or award)
- 4 Grant or award Director acquired 7,375 shares (grant or award)
- 4 Grant or award Director acquired 7,375 shares (grant or award)
- 4 Grant or award Director acquired 7,375 shares (grant or award)
Page 5 of 28 · 550 filings